Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q4 2017 call → NOWe need to determine if management explains the company's current momentum and near-term trajectory chiefly by pointing to a wave of new building, equipping, or capacity-creation being undertaken by other parties, and that this build-out is early or intensifying, with the company already supplying part of what those parties must buy. Let's analyze the transcript. The company is Pacira Pharmaceuticals, selling EXPAREL, a non-opioid pain management drug. The call discusses partnerships, clinical trials, reimbursement, and growth strategies. Key points: - Management discusses partnerships with J&J, Trinity Health, Aetna, etc. These are collaborations to promote opioid-sparing solutions. - They talk about expanding use of EXPAREL through clinical data, education, and partnerships. - They mention CMS reimbursement efforts, seeking separate J code. - They discuss manufacturing expansion in UK, but that's their own capacity. - They talk about J&J sales force, PEAK programs, educational initiatives. Is there any mention of other parties building new capacity? The partnerships are more about education and awareness, not building new facilities. The J&J collaboration is about co-promotion, not building new capacity. The CMS reimbursement is about policy, not building. The question asks about "a wave of new building, equipping, or capacity-creation being undertaken by other parties" - like customers building new plants, hospitals expanding, etc. Here, the company is selling a drug. The demand is from surgeries. There is no mention of hospitals building new surgical centers or expanding capacity. The partnerships are about education and protocols, not about building new infrastructure. Management does mention "shifting many inpatient procedures to the outpatient setting" which could imply building ambulatory surgery centers, but that's not explicitly described as a wave of construction. They talk about "expanding the use of EXPAREL" but that's their own growth. The question also requires that the company is already getting business from this build-out, and that the wave is early and big relative to the company. There is no such description. Thus, the answer is NO. Management explains growth through partnerships, education, reimbursement changes, and their own initiatives, not through a build-out by others. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.